Search research articles
Contact Us
Filters
Showing results (261-270 of 297) with videos related to
Page
of 30
Sort By:
BMJ Open Respiratory Research
|
February 3, 2016
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials
Lisa Lancaster, Carlo Albera, Williamson Z Bradford, et al.
The European Respiratory Journal
|
December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
Paul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Pulmonary Circulation
|
August 26, 2022
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
Sylvia M Nikkho, Manuel J Richter, Eric Shen, et al.
The European Respiratory Journal
|
March 7, 2020
Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry
Oksana A Shlobin, Vasilis Kouranos, Scott D Barnett, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
February 4, 2022
Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study
Marloes P Huitema, Marco C Post, Jan C Grutters, et al.
Respiratory Medicine
|
March 22, 2022
The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry
Rohit Gupta, Robert P Baughman, Steven D Nathan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
November 1, 2022
Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories
Ananth V Charya, Ileana L Ponor, Adam Cochrane, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 21, 2021
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study
Steven D Nathan, Vincent Cottin, Juergen Behr, et al.
Annals of the American Thoracic Society
|
August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and Methods
Bonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 20, 2023
Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant Candidates
Shanti Balasubramanian, Mary E Richert, Hyesik Kong, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 297) with videos related to
Sort By:
Page
of 30
BMJ Open Respiratory Research
|
February 3, 2016
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials
Lisa Lancaster, Carlo Albera, Williamson Z Bradford, et al.
The European Respiratory Journal
|
December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
Paul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Pulmonary Circulation
|
August 26, 2022
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension
Sylvia M Nikkho, Manuel J Richter, Eric Shen, et al.
The European Respiratory Journal
|
March 7, 2020
Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry
Oksana A Shlobin, Vasilis Kouranos, Scott D Barnett, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
February 4, 2022
Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study
Marloes P Huitema, Marco C Post, Jan C Grutters, et al.
Respiratory Medicine
|
March 22, 2022
The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry
Rohit Gupta, Robert P Baughman, Steven D Nathan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
November 1, 2022
Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories
Ananth V Charya, Ileana L Ponor, Adam Cochrane, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
March 21, 2021
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study
Steven D Nathan, Vincent Cottin, Juergen Behr, et al.
Annals of the American Thoracic Society
|
August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and Methods
Bonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 20, 2023
Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant Candidates
Shanti Balasubramanian, Mary E Richert, Hyesik Kong, et al.
Page
of 30